CD163 and lip and oral cavity carcinoma: Interestingly, loss of RGS12 inhibits the expression of M1 macrophage (CD86) but promotes the expression of M2 macrophage (CD163) in 8-week 4NQO-induced oral cancer tissues (Fig. 3a, b).